Page 100 - Haematologica May 2020
P. 100

M. Chimen et al.
   References
1. Kansas GS. Selectins and their ligands: cur- rent concepts and controversies. Blood. 1996;88(9):3259-3287.
2. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflam- mation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678- 689.
3. Liu Y, Shaw SK, Ma S, Yang L, Luscinskas FW, Parkos CA. Regulation of leukocyte transmigration: cell surface interactions and signaling events. J Immunol. 2004;172(1):7- 13.
4. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol. 1995;57:827- 872.
5. McEver RP. Adhesive interactions of leuko- cytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost. 2001;86(3):746-756.
6. Cooper D, Russell J, Chitman KD, Williams MC, Wolf RE, Granger DN. Leukocyte dependence of platelet adhesion in postcap- illary venules. Am J Physiol Heart Circ Physiol. 2004;286(5):H1895-900.
7. Kuroda T, Shiohara E. Leukocyte and platelet depletion protects the liver from damage induced by cholestasis and ischemia-reperfusion in the dog. Scand J Gastroenterol. 1996;31(2):182-190.
8. Lefer AM, Campbell B, Scalia R, Lefer DJ. Synergism between platelets and neu- trophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. Circulation. 1998;29;98(13):1322- 1328.
9. Nishijima K, Kiryu J, Tsujikawa A, et al. In vivo evaluation of platelet--endothelial inter- actions after transient retinal ischemia. Invest Ophthalmol Vis Sci. 2001;42(9):2102- 2109.
10. Salter JW, Krieglstein CF, Issekutz AC, Granger DN. Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation. Am J Physiol Gastrointest Liver Physiol. 2001;281(6):G1432-1439.
11. Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion develop- ment. Blood. 2003;101(7):2661-2666.
12. Huo Y, Schober A, Forlow SB, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2003;9(1):61-67.
13. MassbergS,BrandK,GrunerS,etal.Acrit- ical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196(7):887-896.
14. SachaisBS,TurrentineT,DawickiMcKenna JM, Rux AH, Rader D, Kowalska MA. Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice. Thromb Haemost. 2007;98(5):1108-1113.
15. Kuckleburg CJ, Yates CM, Kalia N, et al. Endothelial cell-borne platelet bridges selec- tively recruit monocytes in human and mouse models of vascular inflammation. Cardiovasc Res. 2011;91(1):134-141.
16. Elalamy I, Chakroun T, Gerotziafas GT, et al. Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients. Thromb Res. 2008;121(6):843-848.
17. GoncalvesR,ZhangX,CohenH,Debrabant A, Mosser DM. Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection. J Exp Med. 2011;208(6):1253-1265.
18. Harding SA, Sommerfield AJ, Sarma J, et al. Increased CD40 ligand and platelet-mono- cyte aggregates in patients with type 1 dia- betes mellitus. Atherosclerosis. 2004;176(2):321-325.
19. Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol. 2001;115(2):451-459.
20. McCabe DJ, Harrison P, Mackie IJ, et al. Platelet degranulation and monocyte- platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol. 2004;125(6):777-787.
21. Parimon T, Li Z, Bolz DD, et al. Staphylococcus aureus alpha-hemolysin promotes platelet-neutrophil aggregate for- mation. J Infect Dis. 2013;208(5):761-770.
depending on the platelet stimulus. J
Proteomics. 2012;76 Spec No.:287-296.
34. Boudreau LH, Duchez AC, Cloutier N, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflamma-
tion. Blood. 2014;124(14):2173-2183.
35. Aatonen MT, Ohman T, Nyman AT, Laitinen S, Gronhilm M, Siljander PRM. Isolation and characterisation of platelet- derived extracellular vesicles. J Extracell
Vesicles. 2014;3.
36. Ponomareva AA, Nevzorova TA,
Mordakhanova ER, Andrianova IA, Litvinov RI. Structural characterisation of platelets and platelets microvesicles. Cell Tissue Biol. 2016; 10(3):217-226.
37. Boilard E, Duchez AC, Brisson A. The diver- sity of platelet microparticles. Curr Opin Hematol. 2015;22(5):437-444.
38. Varon D, Hayon Y, Dashevsky O, Shai E. Involvement of platelet derived microparti- cles in tumor metastasis and tissue regener- ation. Thromb Res. 2012;130 Suppl 1:S98-
22. Tekelioglu Y, Uzun H. Circulating platelet-
leukocyte aggregates in patients with inflammatory bowel disease. J Chin Med 99.
Assoc. 2013;76(4):182-185.
23. Gkaliagkousi E, Corrigall V, Becker S, et al.
Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension. Eur Heart J. 2009;30(24):3048-3054.
24. Nomura S, Kanazawa S, Fukuhara S. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. J Hum Hypertens. 2002;16(8):539-547.
25. Wrigley BJ, Shantsila E, Tapp LD, Lip GY. Increased formation of monocyte-platelet aggregates in ischemic heart failure. Circ Heart Fail. 2013;6(1):127-135.
26. Lippi G, Montagnana M, Salvagno GL, et al. Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte-platelet aggregates. Int J Cardiol. 2007;115(1):101-102.
27. Gando S, Otomo Y. Local hemostasis, immunothrombosis, and systemic dissemi- nated intravascular coagulation in trauma and traumatic shock. Crit Care. 2015;19:72.
28. Ogura H, Kawasaki T, Tanaka H, et al. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J Trauma. 2001;50(5):801-809.
29. Raposo G, Stoorvogel W. Extracellular vesi- cles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373-383.
30. Cloutier N, Tan S, Boudreau LH, et al. The exposure of autoantigens by microparticles underlies the formation of potent inflamma- tory components: the microparticle-associ- ated immune complexes. EMBO Mol Med. 2013;5(2):235-249.
39. Ogata N, Imaizumi M, Nomura S, et al. Increased levels of platelet-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract. 2005;68(3):193-201.
40. Nomura S, Suzuki M, Katsura K, et al. Platelet-derived microparticles may influ- ence the development of atherosclerosis in diabetes mellitus. Atherosclerosis. 1995;116 (2):235-240.
41. FengB,ChenY,LuoY,ChenM,LiX,NiY. Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis. 2010;208(1):264-269.
42. Biasucci LM, Porto I, Di Vito L, et al. Differences in microparticle release in patients with acute coronary syndrome and stable angina. Circ J. 2012;76(9):2174-2182.
43. Chimen M, Yates CM, McGettrick HM, et al. Monocyte Subsets Coregulate Inflammatory Responses by Integrated Signaling through TNF and IL-6 at the Endothelial Cell Interface. J Immunol. 2017;198(7):2834-2843.
44. Daaboul GG, Gagni P, Benussi L, et al. Digital Detection of Exosomes by Interferometric Imaging. Sci Rep. 2016; 6:37246.
45. Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet micropar- ticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol. 2005;25(7):1512-1518.
46. van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothe- lial cells and their relevance for cardiovascu- lar diseases. J Leukoc Biol. 2009;85(2):195-
31. Holme PA, Rosger M, Solum NO, Brosstad F,
Larsen AM, Hovig T. Glycoprotein IIb-IIIa
on platelet-derived microparticles, and microparticle structures studied by electron 204.
microscopy, confocal laser microscopy and crossed radio-immunoelectrophoresis. Platelets. 1996;7(4):207-214.
32. Nomura S, Tandon NN, Nakamura T, Cone J, Fukuhara S, Kambayashi J. High-shear- stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothe- lial cells. Atherosclerosis. 2001;158(2):277- 287.
33. Shai E, Rosa I, Parguina AF, Motahedeh S, Varon D, Garcia A. Comparative analysis of platelet-derived microparticles reveals differ- ences in their amount and proteome
47. Barry OP, Pratico D, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest. 1997;99(9):2118-2127.
48. Ley K. The role of selectins in inflammation and disease. Trends Mol Med. 2003;9(6):263-268.
49. Harding SA, Din JN, Sarma J, et al. Flow cytometric analysis of circulating platelet- monocyte aggregates in whole blood: methodological considerations. Thromb Haemost. 2007;98(2):451-456.
50. Fendl B, Weiss R, Fischer MB, Spittler A,
 1260
  haematologica | 2020; 105(5)
  

































   98   99   100   101   102